• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Updates on Urinary Bladder Tumors With Neuroendocrine Features.神经内分泌特征的膀胱肿瘤最新进展。
Adv Anat Pathol. 2024 May 1;31(3):169-177. doi: 10.1097/PAP.0000000000000433. Epub 2024 Mar 25.
2
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.非腺样脐尿管癌:病理诊断中的显著特征和注意事项。
Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c.
3
Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.膀胱混合性腺癌和神经内分泌肿瘤伴原位癌:一例报告及综合免疫组化分析与文献复习
Int J Surg Pathol. 2019 Sep;27(6):684-692. doi: 10.1177/1066896919839781. Epub 2019 Apr 8.
4
Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.根据2016年世界卫生组织分类的膀胱神经内分泌肿瘤:分子与临床特征
Endocr Pathol. 2016 Sep;27(3):188-99. doi: 10.1007/s12022-016-9444-5.
5
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3.表达GATA 3的膀胱高分化神经内分泌肿瘤
Virchows Arch. 2023 Apr;482(4):783-788. doi: 10.1007/s00428-022-03478-2. Epub 2022 Dec 22.
6
Unilateral axillary lymph node metastasis from small cell neuroendocrine carcinoma of the urinary bladder.膀胱小细胞神经内分泌癌单侧腋窝淋巴结转移
Cytopathology. 2021 May;32(3):371-373. doi: 10.1111/cyt.12915. Epub 2020 Oct 11.
7
[Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].[膀胱原发性小细胞神经内分泌癌的临床病理特征]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Jun;45(3):429-435. doi: 10.3881/j.issn.1000-503X.15514.
8
Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.膀胱高级别神经内分泌癌/小细胞癌与传统膀胱尿路上皮癌的鉴别:一种免疫组织化学方法。
Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):395-9. doi: 10.1097/PAI.0b013e31820eca9a.
9
Well-differentiated neuroendocrine tumors of the lower urinary tract: biologic behavior of a rare entity.下尿路分化良好的神经内分泌肿瘤:一种罕见实体的生物学行为。
Hum Pathol. 2021 Mar;109:53-58. doi: 10.1016/j.humpath.2020.11.014. Epub 2020 Dec 8.
10
Primary large cell neuroendocrine carcinoma of the urinary bladder.原发性膀胱大细胞神经内分泌癌
Int J Urol. 2008 Dec;15(12):1080-3. doi: 10.1111/j.1442-2042.2008.02168.x.

引用本文的文献

1
Molecular Characteristics, Heterogeneity, Plasticity, and Cell of Origin of Neuroendocrine Bladder Cancer.神经内分泌膀胱癌的分子特征、异质性、可塑性及起源细胞
Cancer Heterog Plast. 2025;2(1). doi: 10.47248/chp2502010005. Epub 2025 Mar 6.
2
Small cell carcinoma with rhabdomyosarcomatous differentiation of the urinary bladder: an integrated clinicopathological and molecular characterization of five cases.膀胱小细胞癌伴横纹肌肉瘤分化:5例病例的综合临床病理及分子特征分析
Virchows Arch. 2025 Jul 8. doi: 10.1007/s00428-025-04174-7.
3
Clinical features and prognosis of small cell carcinoma of the bladder: a single center retrospective analysis.膀胱小细胞癌的临床特征与预后:一项单中心回顾性分析
Transl Androl Urol. 2025 Mar 30;14(3):529-539. doi: 10.21037/tau-2024-645. Epub 2025 Mar 26.
4
Unusual coexistence: A case of mixed small and large cell neuroendocrine tumor in a bladder previously affected by bilharzial cystitis.罕见并存情况:一例膀胱中同时存在小细胞和大细胞神经内分泌肿瘤,该膀胱先前患有血吸虫性膀胱炎。
Clin Case Rep. 2024 Sep 16;12(9):e9444. doi: 10.1002/ccr3.9444. eCollection 2024 Sep.

本文引用的文献

1
Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer.鉴定小细胞膀胱癌中谱系特异性转录因子定义的分子亚型。
Eur Urol. 2024 Jun;85(6):523-526. doi: 10.1016/j.eururo.2023.05.023. Epub 2023 Jun 27.
2
Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes.尿路上皮癌:不同分化和形态亚型。
Surg Pathol Clin. 2022 Dec;15(4):641-659. doi: 10.1016/j.path.2022.07.003. Epub 2022 Oct 13.
3
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.DLL3 作为神经内分泌肿瘤治疗的新兴靶点。
Oncologist. 2022 Nov 3;27(11):940-951. doi: 10.1093/oncolo/oyac161.
4
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.POU2F3 在小细胞肺癌中的表现:以其在神经内分泌低分化小细胞肺癌中的诊断效用为重点的临床病理和基因组分析。
J Thorac Oncol. 2022 Sep;17(9):1109-1121. doi: 10.1016/j.jtho.2022.06.004. Epub 2022 Jun 24.
5
Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.前列腺癌中的神经内分泌分化:连续系列的当代评估。
Histopathology. 2022 Aug;81(2):246-254. doi: 10.1111/his.14707. Epub 2022 Jul 11.
6
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.局部和转移性尿路上皮小细胞癌的长期预后和新辅助化疗患者的基因组分析。
Clin Genitourin Cancer. 2022 Oct;20(5):431-441. doi: 10.1016/j.clgc.2022.05.005. Epub 2022 May 11.
7
Head-to-Head Comparison of the Expression Differences of NECTIN-4, TROP-2, and HER2 in Urothelial Carcinoma and Its Histologic Variants.尿路上皮癌及其组织学变体中NECTIN-4、TROP-2和HER2表达差异的头对头比较
Front Oncol. 2022 Apr 19;12:858865. doi: 10.3389/fonc.2022.858865. eCollection 2022.
8
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.TROP2 表达横跨尿路上皮癌的分子亚型和恩福妥珠单抗耐药细胞。
Eur Urol Oncol. 2022 Dec;5(6):714-718. doi: 10.1016/j.euo.2021.11.005. Epub 2022 Feb 23.
9
() Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract.()泌尿系统癌中的拷贝数变化(增加)与免疫检查点阻断疗法的反应
Bladder Cancer. 2021;7(4):395-400. doi: 10.3233/blc-201532. Epub 2021 Dec 13.
10
Lung neuroendocrine neoplasms: recent progress and persistent challenges.肺神经内分泌肿瘤:最新进展与持续挑战。
Mod Pathol. 2022 Jan;35(Suppl 1):36-50. doi: 10.1038/s41379-021-00943-2. Epub 2021 Oct 18.

神经内分泌特征的膀胱肿瘤最新进展。

Updates on Urinary Bladder Tumors With Neuroendocrine Features.

机构信息

Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD.

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center New York, NY.

出版信息

Adv Anat Pathol. 2024 May 1;31(3):169-177. doi: 10.1097/PAP.0000000000000433. Epub 2024 Mar 25.

DOI:10.1097/PAP.0000000000000433
PMID:38523484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11006587/
Abstract

The most common neuroendocrine tumor in the urinary bladder is small cell carcinoma, which can be pure or mixed with components of urothelial or other histologic subtypes. Large cell neuroendocrine carcinoma of the bladder is rare and remains ill-defined but is increasingly recognized. Well-differentiated neuroendocrine tumor and paraganglioma can arise in the bladder but are very rare in this location. Recent advances in molecular characterization allowed for better classification and may offer improved stratification of these tumors.

摘要

膀胱最常见的神经内分泌肿瘤是小细胞癌,可以是纯的,也可以是与尿路上皮或其他组织学亚型混合的。膀胱大细胞神经内分泌癌很少见,定义不明确,但越来越受到认识。分化良好的神经内分泌肿瘤和副神经节瘤也可以发生在膀胱,但在这个部位非常罕见。分子特征的最新进展有助于更好的分类,并可能为这些肿瘤提供更好的分层。